Artia Global Partners LP Eye Point Pharmaceuticals, Inc. Transaction History
Artia Global Partners LP
- $631 Billion
- Q3 2025
A detailed history of Artia Global Partners LP transactions in Eye Point Pharmaceuticals, Inc. stock. As of the latest transaction made, Artia Global Partners LP holds 628,367 shares of EYPT stock, worth $7.45 Million. This represents 1.42% of its overall portfolio holdings.
Number of Shares
628,367
Previous 316,700
98.41%
Holding current value
$7.45 Million
Previous $2.98 Billion
200.25%
% of portfolio
1.42%
Previous 0.72%
Shares
7 transactions
Others Institutions Holding EYPT
# of Institutions
167Shares Held
68MCall Options Held
421KPut Options Held
401K-
Cormorant Asset Management, LP Boston, MA8.33MShares$98.7 Million18.35% of portfolio
-
Suvretta Capital Management, LLC New York, NY6.19MShares$73.4 Million2.57% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA5.56MShares$65.9 Million0.13% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA4.42MShares$52.3 Million0.12% of portfolio
-
Franklin Resources Inc San Mateo, CA4.17MShares$49.4 Million0.02% of portfolio
About EyePoint Pharmaceuticals, Inc.
- Ticker EYPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,072,200
- Market Cap $404M
- Description
- EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...